Company intelligence / Profile preview

Ipekyolu Ilac Ltd. Sti

Ownership: Private
Development stage: Other

Overview

Ipekyolu Ilac Ltd. Sti is a Turkish pharmaceutical company focused on developing small molecule therapies for rare and inflammatory diseases such as Behçet disease and Familial Mediterranean Fever. The company sponsors clinical trials in collaboration with academic institutions like Istanbul University-Cerrahpasa School of Medicine, with at least one program in Phase 2 clinical development involving topical pentoxifylline formulations.[2][5]

Therapeutic areas: Immunology
Modalities: Small molecules (e.g., pentoxifylline, colchicine)[2][6]
Industry: Biotech

Partnerships

Collaboration with Istanbul University-Cerrahpasa School of Medicine on clinical trials[2][6]

Beyond the preview

Go deeper on Ipekyolu Ilac Ltd. Sti.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ipekyolu Ilac Ltd. Sti.

Explore the full profile